Cue Biopharma Cash Flow Statement (2017-2025) | CUE

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Cash Flow Statement	Mar2021	Jun2021	Sep2021	Dec2021	Mar2022	Jun2022	Sep2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025	Dec2025
Operating Activities
Net Income (Quarter)	-12.51M	-10.28M	-12.99M	-7.89M	-14.26M	-13.21M	-10.96M	-14.23M	-12.74M	-12.95M	-10.72M	-12.93M	-12.11M	-9.96M	-8.47M	23.62M	-12.13M	-8.44M	-7.37M	23.21M
Depreciation and Depletion (Quarter)	0.22M	0.23M	0.23M	0.23M	0.22M	0.21M	0.20M	0.20M	0.17M	0.10M	0.10M	0.14M	0.10M	0.10M	0.10M	0.10M	0.10M	0.10M	0.08M	0.07M
Share-based Compensation (Quarter)	2.44M	2.85M	3.25M	2.97M	3.01M	2.31M	2.06M	2.11M	2.00M	2.04M	2.07M	2.07M	1.95M	1.75M	1.58M	1.56M	1.34M	1.26M	1.53M	0.61M
Gains from Sales and Divestitures (Quarter)	0.02M	0.02M	0.10M	0.13M	0.09M	0.09M	0.10M	0.10M
Gains from Investment Securities (Quarter)	0.87M	0.12M	0.04M		0.82M	0.82M	0.83M	1.68M	7.04M	0.37M	2.58M		1.87M	2.46M	10.61M	1.40M	12.34M	1.53M	13.78M	2.71M
Non-cash Items (Quarter)	3.13M	3.25M	3.48M	3.56M	3.90M	4.06M	4.36M	4.40M	4.36M	4.45M	4.37M	4.60M	5.09M	4.94M	5.24M	5.15M	5.98M	6.32M	7.23M	7.34M
Cash from Operations (Quarter)	-11.79M	-9.77M	-6.63M	-10.65M	-11.57M	-12.85M	-6.87M	-10.51M	-10.83M	-10.37M	-7.80M	-10.96M	-9.78M	-9.99M	-7.53M	-9.03M	-8.17M	-3.42M	-9.02M	-1.08M
Depreciation, Depletion & Amortization
Amortizatization of Intangibles (Quarter)	-0.01M			3.04M			-0.10M	-0.22M	-0.15M	-0.07M	-0.01M									-0.03M
Amortization of Deferred Charges (Quarter)					0.00M	0.01M	0.01M	0.01M	0.01M	0.01M	0.01M	0.01M	0.01M	0.01M	0.01M	0.01M	0.01M	0.01M	0.01M	0.01M
Depreciation & Amortization (CF) (Quarter)	0.32M	0.31M	0.32M	0.31M	0.30M	0.21M	0.20M	0.20M	0.18M	0.14M	0.13M	0.11M	0.10M	0.10M	0.10M	0.10M	0.10M	0.10M	0.08M	0.68M
Change in Working Capital
Change in Receivables (Quarter)	-0.00M	0.49M	-1.13M	2.37M	-2.22M	-0.19M	0.06M	-0.74M	0.14M	0.94M	0.53M	0.04M	-0.30M	0.45M	1.30M	-2.21M	-0.94M	0.53M	-0.14M	5.16M
Change in Account Payables (Quarter)	0.20M	0.72M	-0.52M	0.12M	0.03M	-1.05M	0.48M	0.63M	-0.58M	0.20M	0.12M	1.02M	0.42M	-0.01M	2.57M	-3.65M	0.96M	-0.16M	-1.28M	1.60M
Change in Accured Expenses (Quarter)	-0.81M	0.03M	1.99M	0.63M	-1.22M	0.15M	0.32M	-0.33M	-0.71M	1.23M	1.05M	-0.98M	1.07M	-0.65M	-1.36M	-0.29M	1.32M	-2.71M	0.35M	-0.26M
Other Working Capital Changes (Quarter)	1.59M	1.20M	-6.30M	6.42M	0.10M	0.00M	0.00M	-0.88M	-0.65M			2.46M	1.00M	-0.22M	-0.34M	-2.43M	-0.79M	2.34M	0.76M	-4.88M
Investing Activities
Capital Expenditures (Quarter)	0.65M	0.25M	0.01M	39.00	0.03M	0.07M	0.08M	0.00M					0.06M	0.01M	-0.00M	0.00M	0.15M	0.03M
Sales of Property, Plant and Equipment (Quarter)			0.00M	550.00		0.00M	0.00M		0.00M						0.10M	0.00M				0.02M
Cash from Investing Activities (Quarter)	9.35M	-0.23M	-0.01M	511.00	-0.03M	-0.06M	-29.52M	5.00M	15.00M	5.00M	5.00M		-0.06M	-0.01M	0.10M	-0.00M	-0.15M	-0.03M	-6.77M	7.02M
Financing Activities
Other financing activities (Quarter)					0.14M			-0.00M
Cash from Financing Activities (Quarter)	0.83M	10.67M	0.35M	7.38M	15.16M	11.11M	-0.01M	27.40M	0.39M	2.10M	4.59M	4.78M	2.35M	-1.00M	9.82M	-0.93M	-1.00M	17.80M	0.00M	9.49M
Additional items
Change in Cash (Quarter)	-1.61M	0.66M	-6.29M	-3.26M	3.56M	-1.80M	-36.40M	21.89M	4.56M	-3.27M	1.79M	-6.18M	-7.49M	-11.00M	2.39M	-9.96M	-9.32M	14.36M	-15.79M	15.44M
Free Cash Flow (Quarter)	-12.44M	-10.02M	-6.64M	-10.65M	-11.60M	-12.91M	-6.95M	-10.52M	-10.83M	-10.37M	-7.80M	-10.96M	-9.84M	-10.00M	-7.53M	-9.03M	-8.32M	-3.44M	-9.02M	-1.08M
Net Cash Flow (Quarter)	-1.61M	0.66M	-6.29M	-3.26M	3.56M	-1.80M	-36.40M	21.89M	4.56M	-3.27M	1.79M	-6.18M	-7.49M	-11.00M	2.39M	-9.96M	-9.32M	14.36M	-15.79M	15.44M

Research Tools

Cue Biopharma Cash Flow Statement (2017-2025) | CUE

Create an account

Sign In

Reset Password